Erythrocyte aggregation is the reversible clumping of red blood cells (RBCs) under low shear forces or at stasis.
Stacked red blood cells flow across drying slide
Erythrocytes aggregate in a special way, forming rouleaux. Rouleaux are stacks of erythrocytes which form because of the unique discoid shape of the cells in vertebrate body. The flat surface of the discoid RBCs give them a large surface area to make contact and stick to each other; thus, forming a rouleau. Rouleaux formation takes place only in suspensions of RBC containing high-molecular, fibrilar proteins or polymers in the suspending medium (often Dextran-2000 in-vitro). The most important protein causing rouleaux formation in plasma is fibrinogen. RBC suspended in simple salt solutions do not form rouleaux.[1][2][3]
Mechanism[edit]
Erythrocyte aggregation is a physiological phenomenon that takes places in normal blood under low-flow conditions or at stasis. The presence or increased concentrations of acute phase proteins, particularly fibrinogen, results in enhanced erythrocyte aggregation.
Current experimental and theoretical evidence supports the mechanism related to the depletion of high-molecular weight molecules (e.g., fibrinogen) for rouleaux formation.[4] This mechanism is also known as “chemiosmotic hypothesis” for aggregation.[5]
Erythrocyte aggregation is determined by both suspending phase (blood plasma) and cellular properties. Surface properties of erythrocytes, such as surface charge density strongly influence the extent and time course of aggregation.
Effects[edit]
Erythrocyte aggregation is the main determinant of blood viscosity at low shear rate. Rouleaux formation also determines Erythrocyte sedimentation rate which is a non-specific indicator of the presence of disease.[6]
Influence of erythrocyte aggregation on in vivo blood flow is still a controversial issue.[7] Enhanced aggregation affects venous hemodynamics.[8] Erythrocyte aggregation also affects hemodynamic mechanisms in microcirculation and vascular control mechanisms.[9]
Causes[edit]
Conditions which cause increased rouleaux formation include infections, inflammatory and connective tissue disorders, and cancers (most common in multiple myeloma). It also occurs in diabetes mellitus and is one of the causative factors for microvascular occlusion in diabetic retinopathy.
Erythrocyte sedimentation rate closely reflects the extent of aggregation, therefore can be used as a measure of aggregation. Erythrocyte aggregation can also be quantitated by monitoring optical properties of blood during the time course of aggregation process.[10]
Measurement[edit]
blood film
syllectometry
intravital microscopy
high-frequency ultrasound
Optical coherence tomography
References[edit]
^Chien S, Sung LA (1987). "Physicochemical basis and clinical implications of red cell aggregation". Clinical Hemorheology. 7: 71–91.
^Chien S, Jan KM (1973). "Ultrastructural basis of the mechanism of rouleaux formation". Microvascular Research. 5 (2): 155–66. doi:10.1016/0026-2862(73)90068-X. PMID 4694282.
^Mesielman HJ (1993). "Red blood cell role in RBC aggregation: 1963-1993 and beyond". Clinical Hemorheology. 13: 575–592.
^Baskurt OK, Meiselman HJ (2008). "RBC Aggregation: More Important than RBC Adhesion to Endothelial Cells as a Determinant of In Vivo Blood Flow in Health and Disease". Microcirculation. 15 (7): 585–590. doi:10.1080/10739680802107447. PMID 18608991.
^Cabel M, Meiselman HJ, Popel AS, Johnson PC (1997). "Contribution of red blood cell aggregation to venous vascular resistance in skeletal muscle". American Journal of Physiology. 272 (2 Pt 2): H1020–H1032. PMID 9124410.
^Baskurt OK (2008). "In vivo correlates of altered blood rheology". Biorheology. 45 (6): 629–638. PMID 19065010.
^Baskurt OK, Uyuklu M, Ulker P, et al. (2009). "Comparison of three instruments for measuring red blood cell aggregation". Clinical Hemorheology and Microcirculation. 43 (4): 283–298. doi:10.3233/CH-2009-1240. PMID 19996518.
v
t
e
Myeloid blood cells and plasma
Hematopoiesis
Myelopoiesis (CFU-GEMM)
CFU-GM
Granulopoiesis
Myeloblast
Promyelocyte
Myelocyte
Metamyelocyte
Band cell
Monocytopoiesis
Monoblast
Promonocyte
MEP
Thrombopoiesis
Megakaryoblast
Promegakaryocyte
Erythropoiesis
Proerythroblast
Normoblast
Reticulocyte
General
Extramedullary hematopoiesis
Myeloid tissue
Granulocytes
Myeloblast
Band cell
Neutrophil
Basophil
CFU-Baso
Eosinophil
CFU-Eos
Mast cell
CFU-Mast
Monocytes
Macrophages
Histiocytes
Kupffer cells
Alveolar macrophage
Microglia
Osteoclasts
Epithelioid cells
giant cells
Langhans giant cells
Foreign-body giant cell
Touton giant cells
Other
Antigen-presenting cells
Dendritic cells
Langerhans cell
CFU-DL
Monoblast
MPS
Platelets
CFU-Meg
Megakaryoblast
Promegakaryocyte
Megakaryocyte
Red blood cells
Reticulocyte
Nucleated red blood cell
CFU-E
Immune response
Leukocyte extravasation
Phagocytosis
Intrinsic immunity
Other
Precursor cells
CFU-GM
Megakaryocyte–erythroid progenitor cell
CFU-GEMM
Myelomonocyte
Other
Phagocyte
Plasma
Hematopoietic system
Hematopoietic stem cell
This article is licensed under CC BY-SA 3.0. Original source: https://en.wikipedia.org/wiki/Erythrocyte aggregation Status: article is cached